March 20, 2024 · Form 4 insider transaction
Pizzuti Dana bought 4,375 shares of Crinetics Pharmaceuticals, Inc. at $16.89 per share, a transaction worth $73.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.